Sekisui Jushi (4212) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
13 May, 2026Executive summary
Net sales rose 5.3% year-over-year to ¥78,163 million for the fiscal year ended March 31, 2026, with operating profit up 13.4% to ¥5,685 million and ordinary profit up 14.9% to ¥6,261 million.
Profit attributable to owners of parent increased 12.2% year-over-year to ¥3,975 million, and comprehensive income surged 60.3% to ¥7,940 million.
The company finalized provisional accounting for a business combination, impacting comparative figures.
Financial highlights
EBITDA increased to ¥9,718 million (13.6% margin), up from ¥8,552 million (13.3%) year-over-year.
Basic earnings per share rose to ¥130.51 from ¥112.06 year-over-year.
Equity-to-asset ratio improved to 69.6% from 68.5% year-over-year.
Cash flows from operating activities increased to ¥7,994 million, while investing and financing cash flows were negative at ¥4,326 million and ¥4,634 million, respectively.
Cash and cash equivalents at period end were ¥15,302 million.
Outlook and guidance
For the fiscal year ending March 31, 2027, net sales are forecast to rise 7.5% to ¥84,000 million, with operating profit up 10.8% to ¥6,300 million and profit attributable to owners of parent up 10.7% to ¥4,400 million.
Annual dividend per share is projected to increase to ¥82.00, with a payout ratio of 55.8%.
Latest events from Sekisui Jushi
- Sales rose on M&A gains, but profits fell; 2H outlook and shareholder returns remain strong.4212
Q2 202511 Mar 2026 - Sales up 18.2% YoY, profit down on higher costs; profit growth and higher dividends expected.4212
Q4 202511 Mar 2026 - Sales up 19.5% YoY, but profits fell on higher costs; outlook and dividend growth maintained.4212
Q3 202511 Mar 2026 - Sales and profits increased, with strong outlook and share buyback supporting EPS growth.4212
Q1 202611 Mar 2026 - Profits and sales grew strongly, with higher dividends and continued share buybacks.4212
Q2 202611 Mar 2026 - Sales and profits surged, dividend and share buyback completed, outlook remains strong.4212
Q3 202611 Mar 2026 - Sales rose but profits fell on higher costs; full-year outlook remains positive.4212
Q1 202511 Mar 2026